7 days for fresh specimens; 14 days for archived specimens
Additional Information
The previous lab (Sequenta; South San Francisco) that performed the ClonoSight test was purchased by Adaptive Biotechnologies (Seattle) in May of 2015 and is no longer accepting samples. The ClonoSight test has been replaced by the ClonoSeq assay, which is the name of a similar test that Adaptive Biotechnologies offers. These assays have been shown to be highly concordant.
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
For patients who were originally evaluated (had malignant clones identified) using Sequenta's ClonoSight assay, additional steps may be required prior to continuing with MRD testing on the Adaptive Biotechnologies clonoSEQ assay. It is imperative that the sendout lab be notified if a patient falls into this category so that they can work with Adaptive to transition the patient's testing to clonoSEQ.
Synonyms
Molecular Minimal residual disease testing
MRD
ClonoSight
LymphoSight
Sample Type
EDTA anticoagulated blood or bone marrow
Collect
Lavender top
Amount to Collect
Blood: 10 mL
Bone marrow: 3 mL
Preferred Volume
Blood: 10 mL
Bone marrow: 3 mL
Minimum Volume
Blood: 10 mL
Bone marrow: 3 mL
Remarks
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
Due to limited samle stability, collect samples Monday-Friday only and send via FedEx overnight, avoiding holidays. Samples are accepted by Adaptive Biotechnologies Monday through Saturday from 8AM to 5PM PT.
See Adaptive Biotechnologies website for additional specimen requirements.
Stability (from collection to initiation)
4 days at room temperature
7 days at 4C
Test Code
MOLT
Sendout
Yes
Performing Lab
Adaptive Biotechnologies
Specimen Preparation
Keep samples at room temperature. Forward to CB at room temperature.
Preferred Volume
Blood: 10 mL
Bone marrow: 3 mL
Minimum Volume
Blood: 10 mL
Bone marrow: 3 mL
Stability (from collection to initiation)
4 days at room temperature
7 days at 4C
Additional Information
The previous lab (Sequenta; South San Francisco) that performed the ClonoSight test was purchased by Adaptive Biotechnologies (Seattle) in May of 2015 and is no longer accepting samples. The ClonoSight test has been replaced by the ClonoSeq assay, which is the name of a similar test that Adaptive Biotechnologies offers. These assays have been shown to be highly concordant.
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
For patients who were originally evaluated (had malignant clones identified) using Sequenta's ClonoSight assay, additional steps may be required prior to continuing with MRD testing on the Adaptive Biotechnologies clonoSEQ assay. It is imperative that the sendout lab be notified if a patient falls into this category so that they can work with Adaptive to transition the patient's testing to clonoSEQ.
Approval Required
Yes, for inpatient orders.
Available Stat
No
Test Code
MOLT
Performing Lab
Adaptive Biotechnologies
Sendout
Yes
Methodology
PCR and next-generation sequencing
Remarks
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
Due to limited samle stability, collect samples Monday-Friday only and send via FedEx overnight, avoiding holidays. Samples are accepted by Adaptive Biotechnologies Monday through Saturday from 8AM to 5PM PT.
See Adaptive Biotechnologies website for additional specimen requirements.
Collect
Lavender top
Amount to Collect
Blood: 10 mL
Bone marrow: 3 mL
Sample Type
EDTA anticoagulated blood or bone marrow
Preferred Volume
Blood: 10 mL
Bone marrow: 3 mL
Minimum Volume
Blood: 10 mL
Bone marrow: 3 mL
Specimen Preparation
Keep samples at room temperature. Forward to CB at room temperature.
Synonyms
Molecular Minimal residual disease testing
MRD
ClonoSight
LymphoSight
Stability (from collection to initiation)
4 days at room temperature
7 days at 4C
Reported
7 days for fresh specimens; 14 days for archived specimens
Additional Information
The previous lab (Sequenta; South San Francisco) that performed the ClonoSight test was purchased by Adaptive Biotechnologies (Seattle) in May of 2015 and is no longer accepting samples. The ClonoSight test has been replaced by the ClonoSeq assay, which is the name of a similar test that Adaptive Biotechnologies offers. These assays have been shown to be highly concordant.
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
For patients who were originally evaluated (had malignant clones identified) using Sequenta's ClonoSight assay, additional steps may be required prior to continuing with MRD testing on the Adaptive Biotechnologies clonoSEQ assay. It is imperative that the sendout lab be notified if a patient falls into this category so that they can work with Adaptive to transition the patient's testing to clonoSEQ.
Ordering
Approval Required
Yes, for inpatient orders.
Available Stat
No
Performing Lab
Adaptive Biotechnologies
Methodology
PCR and next-generation sequencing
Reported
7 days for fresh specimens; 14 days for archived specimens
Additional Information
The previous lab (Sequenta; South San Francisco) that performed the ClonoSight test was purchased by Adaptive Biotechnologies (Seattle) in May of 2015 and is no longer accepting samples. The ClonoSight test has been replaced by the ClonoSeq assay, which is the name of a similar test that Adaptive Biotechnologies offers. These assays have been shown to be highly concordant.
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
For patients who were originally evaluated (had malignant clones identified) using Sequenta's ClonoSight assay, additional steps may be required prior to continuing with MRD testing on the Adaptive Biotechnologies clonoSEQ assay. It is imperative that the sendout lab be notified if a patient falls into this category so that they can work with Adaptive to transition the patient's testing to clonoSEQ.
Synonyms
Molecular Minimal residual disease testing
MRD
ClonoSight
LymphoSight
Collection
Sample Type
EDTA anticoagulated blood or bone marrow
Collect
Lavender top
Amount to Collect
Blood: 10 mL
Bone marrow: 3 mL
Preferred Volume
Blood: 10 mL
Bone marrow: 3 mL
Minimum Volume
Blood: 10 mL
Bone marrow: 3 mL
Remarks
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
Due to limited samle stability, collect samples Monday-Friday only and send via FedEx overnight, avoiding holidays. Samples are accepted by Adaptive Biotechnologies Monday through Saturday from 8AM to 5PM PT.
See Adaptive Biotechnologies website for additional specimen requirements.
Stability (from collection to initiation)
4 days at room temperature
7 days at 4C
Processing
Test Code
MOLT
Sendout
Yes
Performing Lab
Adaptive Biotechnologies
Specimen Preparation
Keep samples at room temperature. Forward to CB at room temperature.
Preferred Volume
Blood: 10 mL
Bone marrow: 3 mL
Minimum Volume
Blood: 10 mL
Bone marrow: 3 mL
Stability (from collection to initiation)
4 days at room temperature
7 days at 4C
Result Interpretation
Additional Information
The previous lab (Sequenta; South San Francisco) that performed the ClonoSight test was purchased by Adaptive Biotechnologies (Seattle) in May of 2015 and is no longer accepting samples. The ClonoSight test has been replaced by the ClonoSeq assay, which is the name of a similar test that Adaptive Biotechnologies offers. These assays have been shown to be highly concordant.
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
For patients who were originally evaluated (had malignant clones identified) using Sequenta's ClonoSight assay, additional steps may be required prior to continuing with MRD testing on the Adaptive Biotechnologies clonoSEQ assay. It is imperative that the sendout lab be notified if a patient falls into this category so that they can work with Adaptive to transition the patient's testing to clonoSEQ.
Administrative
Complete View
Approval Required
Yes, for inpatient orders.
Available Stat
No
Test Code
MOLT
Performing Lab
Adaptive Biotechnologies
Sendout
Yes
Methodology
PCR and next-generation sequencing
Remarks
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
Due to limited samle stability, collect samples Monday-Friday only and send via FedEx overnight, avoiding holidays. Samples are accepted by Adaptive Biotechnologies Monday through Saturday from 8AM to 5PM PT.
See Adaptive Biotechnologies website for additional specimen requirements.
Collect
Lavender top
Amount to Collect
Blood: 10 mL
Bone marrow: 3 mL
Sample Type
EDTA anticoagulated blood or bone marrow
Preferred Volume
Blood: 10 mL
Bone marrow: 3 mL
Minimum Volume
Blood: 10 mL
Bone marrow: 3 mL
Specimen Preparation
Keep samples at room temperature. Forward to CB at room temperature.
Synonyms
Molecular Minimal residual disease testing
MRD
ClonoSight
LymphoSight
Stability (from collection to initiation)
4 days at room temperature
7 days at 4C
Reported
7 days for fresh specimens; 14 days for archived specimens
Additional Information
The previous lab (Sequenta; South San Francisco) that performed the ClonoSight test was purchased by Adaptive Biotechnologies (Seattle) in May of 2015 and is no longer accepting samples. The ClonoSight test has been replaced by the ClonoSeq assay, which is the name of a similar test that Adaptive Biotechnologies offers. These assays have been shown to be highly concordant.
All samples for clonoSEQ testing should be sent to Adaptive Biotechnologies in Seattle, WA.
For patients who were originally evaluated (had malignant clones identified) using Sequenta's ClonoSight assay, additional steps may be required prior to continuing with MRD testing on the Adaptive Biotechnologies clonoSEQ assay. It is imperative that the sendout lab be notified if a patient falls into this category so that they can work with Adaptive to transition the patient's testing to clonoSEQ.
